http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103142555-B

Outgoing Links

Predicate Object
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P13-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-593
filingDate 2013-03-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2014-10-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2014-10-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-103142555-B
titleOfInvention Alfacalcidol sustained-release capsule and preparation method thereof
abstract The invention discloses an alfacalcidol sustained-release capsule and a preparation method thereof. The alfacalcidol sustained-release capsule disclosed by the invention is prepared through filling an alfacalcidol sustained-release pellet in a capsule shell; and during preparation, the alfacalcidol sustained-release pellet is obtained through coating a drug-containing layer and a coating layer outside a blank pellet core and then filled in the capsule shell, thereby obtaining the alfacalcidol sustained-release capsule. According to the alfacalcidol sustained-release capsule and the preparation method of the alfacalcidol sustained-release capsule, the drug release is uniform, the aims of long acting and curative effect improving can be reached, and the dosage can be reduced while the same drug action is maintained, so that side effects to patients caused by drug taking are reduced; and the preparation method is simple, the quality of obtained products is stable, and thus, the method is applicable to large-scale production application.
priorityDate 2013-03-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414859239
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID702
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6507
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5282181
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24261
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457707758
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426260387
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6781
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24832091
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538410
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419513769
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419491555

Total number of triples: 29.